Abstract:Background Repressor element 1-silencing transcription (REST)/neuron-restrictive silencer factor is considered a new therapeutic target for neurodegenerative disorders such as Alzheimer’s disease (AD). However, the relationship between AD and REST remains unclear. This study aimed to 1) examine plasma REST levels and REST gene levels in AD patients and 2) further explore the pathological relationships between REST protein levels and cognitive decline in clinical conditions, including medial temporal lobe atrophy. Methods Participants ( n = 252, mean age 68.95 ± 8.78 years) were recruited in Beijing, China, and then divided into a normal cognition (NC) group ( n = 89), an amnestic mild cognitive impairment (aMCI) group ( n = 79), and an AD dementia group ( n = 84) according to diagnostic criteria. All participants underwent neuropsychological assessments, laboratory tests, and neuroimaging scans (magnetic resonance imaging) at baseline. Plasma REST protein levels and the distribution of REST single nucleotide polymorphisms (SNPs) were compared among the three groups. Correlations between cognitive function, neuro-imaging results, and REST levels were determined by a multivariate linear regression analysis. Results The plasma REST levels in both the NC group (430.30 ± 303.43)pg/ml and aMCI group (414.27 ± 263.39)pg/ml were significantly higher than that in the AD dementia group (NC vs AD dementia group, p = 0.034; aMCI vs AD dementia group, p = 0.033). There was no significant difference between the NC and aMCI groups ( p = 0.948). No significant difference was found among the three groups regarding the genotype distribution (rs2227902 and rs3976529 SNPs) of the REST gene. The REST level was correlated with the left medial temporal lobe atrophy index ( r = 0.306, p = 0.023). After 6 months of follow-up, the REST level in the NC group was positively correlated with the change in the Mini-Mental State Examination score ( r = 0.289, p = 0.02). Conclusion The plasma REST protein level is decreased in AD dementia patients, which is associated with memory impairment and left temporal lobe atrophy and may have potential value for clinical diagnosis of AD dementia.

Overexpression of REST Causes Neuronal Injury and Decreases Cofilin Phosphorylation in Mice

Repressor element-1 silencing transcription factor (REST)-dependent epigenetic remodeling is critical to ischemia-induced neuronal death

NRSF regulates age-dependently cognitive ability and its conditional knockout in APP/PS1 mice moderately alters AD-like pathology

REST and Stress Resistance in Ageing and Alzheimer's Disease.

REST protects primary cortical neurons from PrP106-126-induced synaptic damage and neurofibrillary degeneration

Repressor Element-1 Binding Transcription Factor (REST) as a Possible Epigenetic Regulator of Neurodegeneration and MicroRNA-Based Therapeutic Strategies

NRSF/REST Deficiency Impairs Cognitive Abilities in Aged Mice But Does Not Interfere with Memory Deficits of APP/PS1 Transgenic Mice

REST Alleviates Neurotoxic Prion Peptide PrP106-126-induced Primary Cortical Neuronal Death

Plasma Repressor Element 1-Silencing Transcription Factor Levels Are Decreased in Patients with Alzheimer's Disease

REST Overexpression in Mice Causes Deficits in Spontaneous Locomotion

REST alleviates neurotoxic prion peptide-induced synaptic abnormalities, neurofibrillary degeneration and neuronal death partially via LRP6-mediated Wnt-β-catenin signaling.

Silencing of Long Noncoding RNA SOX21-AS1 Relieves Neuronal Oxidative Stress Injury in Mice with Alzheimer’s Disease by Upregulating FZD3/5 Via the Wnt Signaling Pathway

SIRT6-dependent functional switch via K494 modifications of RE-1 silencing transcription factor

Brain-specific NRSF Deficiency Aggravates Dopaminergic Neurodegeneration and Impairs Neurogenesis in the MPTP Mouse Model of Parkinson's Disease.

Rpph1 Upregulates CDC42 Expression and Promotes Hippocampal Neuron Dendritic Spine Formation by Competing with Mir-330-5p.

REST Is Not Resting: REST/NRSF in Health and Disease

Downregulation of the Repressor Element 1-Silencing Transcription Factor (REST) is Associated with Akt-mTOR and Wnt-β-Catenin Signaling in Prion Diseases Models

Dopaminergic REST/NRSF is protective against manganese-induced neurotoxicity in mice

Alteration of NRSF expression exacerbating 1-methyl-4-phenyl-pyridinium ion-induced cell death of SH-SY5Y cells.

Human microRNA-153-3p targets specific neuronal genes and is associated with the risk of Alzheimer's disease.

REST/NRSF-induced changes of ChAT protein expression in the neocortex and hippocampus of the 3xTg-AD mouse model for Alzheimer's disease